Table 5.
A summary of the results of the patient clustering process. The mean values are reported for mean arterial pressure (MAP) and median values are reported for body mass index (BMI).
| General Features | Cluster: | 1 | 2 | 3 | 4 | |
|---|---|---|---|---|---|---|
| n = | 1697 | 392 | 204 | 228 | ||
| Demographics | Age, years | 67.8 | 63.2 | 71.9 | 69.9 | |
| Gender (% male) | 52.6% | 14.0% | 38.7% | 47.8% | ||
| Race (% white) | 85.7% | 76.8% | 75.0% | 78.5% | ||
| Race (% black) | 12.8% | 22.2% | 24.5% | 20.6% | ||
|
| ||||||
| Vital Signs | BMI (kg/m2) (median) | 30.3 | 30.7 | 30 | 31.1 | |
|
| ||||||
| Features Used in Clustering | ||||||
|
| ||||||
| Demographics | Age | 67.8 | 63.2 | 71.9 | 69.9 | |
|
| ||||||
| Vital Signs | MAP before pilot enrollment (mmHg) | 93.2 | 95.7 | 93.3 | 91.4 | |
|
| ||||||
| Medications | Aldosterone antagonists | 3.1% | 0.5% | 43.1% | 75.4% | |
| Beta blockers | 49.3% | 44.9% | 83.3% | 76.8% | ||
| Central alpha agonists | 0.0% | 38.8% | 90.2% | 29.8% | ||
|
| ||||||
| PheWAS Codes | Other forms of heart disease (non-ischemic, non-pulmonary heart disease) | 39.4% | 0.0% | 83.8% | 72.4% | |
| Other disorders of female genital tract (other than inflammatory diseases of pelvis) | 6.1% | 69.9% | 34.3% | 1.3% | ||
| Symptoms involving head and neck | 23.8% | 28.8% | 9.8% | 25.4% | ||
| Other disorders of pancreatic internal secretion (other than diabetes) | 0.4% | 2.0% | 0.0% | 12.7% | ||